-
ICD-10-CM Codes
›
-
Z00-Z99
›
-
Z00-Z13
›
-
Z08-
›
-
2023 ICD-10-CM Diagnosis Code Z08
2023 ICD-10-CM Diagnosis Code Z08
Encounter for follow-up examination after completed treatment for malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
- Z08 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Encntr for follow-up exam after trtmt for malignant neoplasm
- The 2023 edition of ICD-10-CM Z08 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z08 - other international versions of ICD-10 Z08 may differ.
Applicable To- Medical surveillance following completed treatment
Use AdditionalUse Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z08. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- aftercare following medical care (
ICD-10-CM Diagnosis Code Z43
Encounter for attention to artificial openings
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Includes- closure of artificial openings
- passage of sounds or bougies through artificial openings
- reforming artificial openings
- removal of catheter from artificial openings
- toilet or cleansing of artificial openings
Type 2 Excludes- fitting and adjustment of prosthetic and other devices (Z44-Z46)
Z43-ICD-10-CM Diagnosis Code Z49
Encounter for care involving renal dialysis
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code Also- associated end stage renal disease (N18.6)
Z49, ICD-10-CM Diagnosis Code Z51
Encounter for other aftercare and medical care
2016 2017 - Revised Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- follow-up examination after treatment (Z08-Z09)
Z51)
The following code(s) above
Z08 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z08:
Approximate Synonyms
- Follow up exam after cancer treatment completion
- Follow up exam after completion of cancer treatment done
- Vaginal pap, had hysterectomy for cancer
- Vaginal papanicolaou smear with history of hysterectomy for cancer done
Present On AdmissionPOA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
- Z08 is considered exempt from POA reporting.
ICD-10-CM Z08 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 837 Chemotherapy with acute leukemia as secondary diagnosis or with high dose chemotherapy agent with mcc
- 838 Chemotherapy with acute leukemia as secondary diagnosis with cc or high dose chemotherapy agent
- 839 Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc
- 846 Chemotherapy without acute leukemia as secondary diagnosis with mcc
- 847 Chemotherapy without acute leukemia as secondary diagnosis with cc
- 848 Chemotherapy without acute leukemia as secondary diagnosis without cc/mcc
Convert Z08 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to Z08:
-
Code First: Z85
ICD-10-CM Diagnosis Code Z85
Personal history of malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code First- any follow-up examination after treatment of malignant neoplasm (Z08)
Type 2 Excludes- personal history of benign neoplasm (Z86.01-)
- personal history of carcinoma-in-situ (Z86.00-)
Use Additional- code to identify:
- alcohol use and dependence (F10.-)
- exposure to environmental tobacco smoke (Z77.22)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
-
Type 1 Excludes: Z01.41, Z12.72
ICD-10-CM Diagnosis Code Z01.41
Encounter for routine gynecological examination
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Applicable To- Encounter for general gynecological examination with or without cervical smear
- Encounter for gynecological examination (general) (routine) NOS
- Encounter for pelvic examination (annual) (periodic)
Type 1 Excludes- gynecologic examination status-post hysterectomy for malignant condition (Z08)
- screening cervical pap smear not a part of a routine gynecological examination (Z12.4)
Use Additional- code:
- for screening for human papillomavirus, if applicable, (Z11.51)
- for screening vaginal pap smear, if applicable (Z12.72)
- to identify acquired absence of uterus, if applicable (Z90.71-)
ICD-10-CM Diagnosis Code Z12.72
Encounter for screening for malignant neoplasm of vagina
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Female Dx POA Exempt
Applicable To- Vaginal pap smear status-post hysterectomy for non-malignant condition
Type 1 Excludes- vaginal pap smear status-post hysterectomy for malignant conditions (Z08)
Use Additional- code to identify acquired absence of uterus (Z90.71-)
- Examination (for) (following) (general) (of) (routine) Z00.00
ICD-10-CM Diagnosis Code Z00.00
Encounter for general adult medical examination without abnormal findings
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Adult Dx (15-124 years) POA Exempt
Applicable To- Encounter for adult health check-up NOS
- following
- treatment (for) Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- combined NEC Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- malignant neoplasm Z08
- follow-up (routine) (following) Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- chemotherapy NEC Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- radiotherapy NEC Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- surgery NEC Z09
ICD-10-CM Diagnosis Code Z09
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To- Medical surveillance following completed treatment
Type 1 Excludes- aftercare following medical care (Z43-Z49, Z51)
- surveillance of contraception (Z30.4-)
- surveillance of prosthetic and other medical devices (Z44-Z46)
Use Additional- code to identify any applicable history of disease code (Z86.-, Z87.-)
- malignant neoplasm Z08
ICD-10-CM Codes Adjacent To Z08
Z05.42 Observation and evaluation of newborn for suspected metabolic condition ruled out
Z05.43 Observation and evaluation of newborn for suspected immunologic condition ruled out
Z05.5 Observation and evaluation of newborn for suspected gastrointestinal condition ruled out
Z05.6 Observation and evaluation of newborn for suspected genitourinary condition ruled out
Z05.7 Observation and evaluation of newborn for suspected skin, subcutaneous, musculoskeletal and connective tissue condition ruled out
Z05.71 Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out
Z05.72 Observation and evaluation of newborn for suspected musculoskeletal condition ruled out
Z05.73 Observation and evaluation of newborn for suspected connective tissue condition ruled out
Z05.8 Observation and evaluation of newborn for other specified suspected condition ruled out
Z05.9 Observation and evaluation of newborn for unspecified suspected condition ruled out
Z08
Encounter for follow-up examination after completed treatment for malignant neoplasm
Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
Z11 Encounter for screening for infectious and parasitic diseases
Z11.0 Encounter for screening for intestinal infectious diseases
Z11.1 Encounter for screening for respiratory tuberculosis
Z11.2 Encounter for screening for other bacterial diseases
Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
Z11.5 Encounter for screening for other viral diseases
Z11.51 Encounter for screening for human papillomavirus (HPV)
Z11.52 Encounter for screening for COVID-19
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.